Vincerx Pharma, Inc. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Vincerx Pharma, Inc. had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $3.10 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2025-05-15
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $3.10M.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $3.70M.
- 2024-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $5.80M.
- 2024-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $7.60M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2025-03-31 | $3.10M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $3.70M 10-K · filed 2025-03-27 |
| 2024-09-30 | $5.80M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $7.60M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $8.10M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $700.00K 10-K · filed 2024-03-29 |
| 2023-09-30 | $1.30M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.80M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $4.10M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.20M 10-K · filed 2023-03-28 |
| 2022-09-30 | $7.20 10-Q · filed 2022-11-10 |
| 2022-06-30 | $9.50 10-Q · filed 2022-08-11 |
| 2022-03-31 | $13.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $13.80 10-K · filed 2022-03-29 |
| 2021-09-30 | $19.10 10-Q · filed 2021-11-12 |
| 2021-06-30 | $23.00 10-Q · filed 2021-08-12 |
| 2021-03-31 | $16.40 10-Q · filed 2021-05-17 |
| 2020-12-31 | $8.10 10-K/A · filed 2021-05-14 |